SARS-CoV-2 Omicron subvariants progressively adapt to human cells with altered host cell entry

被引:4
作者
Sakurai, Yasuteru [1 ,2 ,3 ]
Okada, Sayaka [2 ]
Ozeki, Takehiro [2 ,4 ]
Yoshikawa, Rokusuke [1 ,2 ]
Kinoshita, Takaaki [2 ]
Yasuda, Jiro [1 ,2 ,3 ,4 ]
机构
[1] Nagasaki Univ, Inst Trop Med NEKKEN, Dept Emerging Infect Dis, Nagasaki, Japan
[2] Nagasaki Univ, Natl Res Ctr Control & Prevent Infect Dis CCPID, Dept Emerging Infect Dis, Nagasaki, Japan
[3] Nagasaki Univ, Sch Trop Med & Global Hlth, Nagasaki, Japan
[4] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki, Japan
基金
日本学术振兴会;
关键词
SARS-CoV-2; Omicron; adaptation; spike; host cell entry; INFECTION; SPIKE;
D O I
10.1128/msphere.00338-24
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant exhibits high transmissibility with a strong immune escape ability and causes frequent large-scale global infections by producing predominant subvariants. Here, using human upper/lower airway and intestinal cells, we examined the previously dominant BA.1-BA.5 and BA.2.75 subvariants, together with the recently emerged XBB/BQ lineages, in comparison to the former Delta variant. We observed a tendency for each virus to demonstrate higher growth capability than the previously dominant subvariants. Unlike human bronchial and intestinal cells, nasal epithelial cells accommodated the efficient entry of certain Omicron subvariants, similar to the Delta variant. In contrast to the Delta's reliance on cell-surface transmembrane protease serine 2, all tested Omicron variants depended on endosomal cathepsin L. Moreover, S1/S2 cleavage of early Omicron spikes was less efficient, whereas recent viruses exhibit improved cleavage efficacy. Our results show that the Omicron variant progressively adapts to human cells through continuous endosome-mediated host cell entry.IMPORTANCESARS-CoV-2, the causative agent of coronavirus disease 2019, has evolved into a number of variants/subvariants, which have generated multiple global waves of infection. In order to monitor/predict virological features of emerging variants and determine appropriate strategies for anti-viral development, understanding conserved or altered features of evolving SARS-CoV-2 is important. In this study, we addressed previously or recently predominant Omicron subvariants and demonstrated the gradual adaptation to human cells. The host cell entry route, which was altered from the former Delta variant, was conserved among all tested Omicron subvariants. Collectively, this study revealed both changing and maintained features of SARS-CoV-2 during the Omicron variant evolution. SARS-CoV-2, the causative agent of coronavirus disease 2019, has evolved into a number of variants/subvariants, which have generated multiple global waves of infection. In order to monitor/predict virological features of emerging variants and determine appropriate strategies for anti-viral development, understanding conserved or altered features of evolving SARS-CoV-2 is important. In this study, we addressed previously or recently predominant Omicron subvariants and demonstrated the gradual adaptation to human cells. The host cell entry route, which was altered from the former Delta variant, was conserved among all tested Omicron subvariants. Collectively, this study revealed both changing and maintained features of SARS-CoV-2 during the Omicron variant evolution.
引用
收藏
页数:16
相关论文
共 61 条
[31]   Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2 [J].
Monteil, Vanessa ;
Kwon, Hyesoo ;
Prado, Patricia ;
Hagelkruys, Astrid ;
Wimmer, Reiner A. ;
Stahl, Martin ;
Leopoldi, Alexandra ;
Garreta, Elena ;
del Pozo, Carmen Hurtado ;
Prosper, Felipe ;
Romero, Juan Pablo ;
Wirnsberger, Gerald ;
Zhang, Haibo ;
Slutsky, Arthur S. ;
Conder, Ryan ;
Montserrat, Nuria ;
Mirazimi, Ali ;
Penninger, Josef M. .
CELL, 2020, 181 (04) :905-+
[32]   Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection [J].
Natarajan, Aravind ;
Zlitni, Soumaya ;
Brooks, Erin F. ;
Vance, Summer E. ;
Dahlen, Alex ;
Hedlin, Haley ;
Park, Ryan M. ;
Han, Alvin ;
Schmidtke, Danica T. ;
Verma, Renu ;
Jacobson, Karen B. ;
Parsonnet, Julie ;
Bonilla, Hector F. ;
Singh, Upinder ;
Pinsky, Benjamin A. ;
Andrews, Jason R. ;
Jagannathan, Prasanna ;
Bhatt, Ami S. .
MED, 2022, 3 (06) :371-+
[33]   Infection of primary nasal epithelial cells differentiates among lethal and seasonal human coronaviruses [J].
Otter, Clayton J. ;
Fausto, Alejandra ;
Tan, Li Hui ;
Khosla, Alisha S. ;
Cohen, Noam A. ;
Weiss, Susan R. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2023, 120 (15)
[34]   Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV [J].
Ou, Xiuyuan ;
Liu, Yan ;
Lei, Xiaobo ;
Li, Pei ;
Mi, Dan ;
Ren, Lili ;
Guo, Li ;
Guo, Ruixuan ;
Chen, Ting ;
Hu, Jiaxin ;
Xiang, Zichun ;
Mu, Zhixia ;
Chen, Xing ;
Chen, Jieyong ;
Hu, Keping ;
Jin, Qi ;
Wang, Jianwei ;
Qian, Zhaohui .
NATURE COMMUNICATIONS, 2020, 11 (01)
[35]   Evolution of the SARS-CoV-2 Omicron spike [J].
Parsons, Ruth J. ;
Acharya, Priyamvada .
CELL REPORTS, 2023, 42 (12)
[36]   The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets [J].
Peacock, Thomas P. ;
Goldhill, Daniel H. ;
Zhou, Jie ;
Baillon, Laury ;
Frise, Rebecca ;
Swann, Olivia C. ;
Kugathasan, Ruthiran ;
Penn, Rebecca ;
Brown, Jonathan C. ;
Sanchez-David, Raul Y. ;
Braga, Luca ;
Williamson, Maia Kavanagh ;
Hassard, Jack A. ;
Staller, Ecco ;
Hanley, Brian ;
Osborn, Michael ;
Giacca, Mauro ;
Davidson, Andrew D. ;
Matthews, David A. ;
Barclay, Wendy S. .
NATURE MICROBIOLOGY, 2021, 6 (07) :899-+
[37]  
Puelles VG, 2020, NEW ENGL J MED, V383, P590, DOI [10.1056/NEJMc2013400, 10.1056/NEJMc2011400]
[38]   SARS-CoV-2 evolution in the Omicron era [J].
Roemer, Cornelius ;
Sheward, Daniel J. ;
Hisner, Ryan ;
Gueli, Federico ;
Sakaguchi, Hitoshi ;
Frohberg, Nicholas ;
Schoenmakers, Josette ;
Sato, Kenta ;
O'Toole, Aine ;
Rambaut, Andrew ;
Pybus, Oliver G. ;
Ruis, Christopher ;
Murrell, Ben ;
Peacock, Thomas P. .
NATURE MICROBIOLOGY, 2023, 8 (11) :1952-1959
[39]   Virological characteristics of the SARS-CoV-2 Omicron BA.2.75 variant [J].
Saito, Akatsuki ;
Tamura, Tomokazu ;
Zahradnik, Jiri ;
Deguchi, Sayaka ;
Tabata, Koshiro ;
Anraku, Yuki ;
Kimura, Izumi ;
Ito, Jumpei ;
Yamasoba, Daichi ;
Nasser, Hesham ;
Toyoda, Mako ;
Nagata, Kayoko ;
Uriu, Keiya ;
Kosugi, Yusuke ;
Fujita, Shigeru ;
Shofa, Maya ;
Begum, Mst Monira ;
Shimizu, Ryo ;
Oda, Yoshitaka ;
Suzuki, Rigel ;
Ito, Hayato ;
Nao, Naganori ;
Wang, Lei ;
Tsuda, Masumi ;
Yoshimatsu, Kumiko ;
Kuramochi, Jin ;
Kita, Shunsuke ;
Sasaki-Tabata, Kaori ;
Fukuhara, Hideo ;
Maenaka, Katsumi ;
Yamamoto, Yuki ;
Nagamoto, Tetsuharu ;
Asakura, Hiroyuki ;
Nagashima, Mami ;
Sadamasu, Kenji ;
Yoshimura, Kazuhisa ;
Ueno, Takamasa ;
Schreiber, Gideon ;
Takaori-Kondo, Akifumi ;
Shirakawa, Kotaro ;
Sawa, Hirofumi ;
Irie, Takashi ;
Hashiguchi, Takao ;
Takayama, Kazuo ;
Matsuno, Keita ;
Tanaka, Shinya ;
Ikeda, Terumasa ;
Fukuhara, Takasuke ;
Sato, Kei .
CELL HOST & MICROBE, 2022, 30 (09) :1540-+
[40]   5-amino levulinic acid inhibits SARS-CoV-2 infection in vitro [J].
Sakurai, Yasuteru ;
Tun, Mya Myat Ngwe ;
Kurosaki, Yohei ;
Sakura, Takaya ;
Inaoka, Daniel Ken ;
Fujine, Kiyotaka ;
Kita, Kiyoshi ;
Morita, Kouichi ;
Yasuda, Jiro .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2021, 545 :203-207